![Max Lataillade](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max Lataillade
Directeur Technique/Scientifique/R&D chez
CYTODYN INC.
Profil
Max Lataillade currently works at Yale University School of Medicine, as Assistant Professor and CytoDyn, Inc., as Senior Vice President & Head-Clinical Development from 2024.
Dr. Lataillade received his doctorate degree from the University of Medicine & Dentistry of New Jersey.
Postes actifs de Max Lataillade
| Sociétés | Poste | Début |
|---|---|---|
| CYTODYN INC. | Directeur Technique/Scientifique/R&D | 08/10/2024 |
Formation de Max Lataillade
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
